References
- Abdel-Barry JA, Abdel-Hassan IA, Al-Hakiem MH (1997): Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum-graecum. leaf in normal and alloxan induced diabetic rats. J Ethnopharmacol 58: 149–155. [INFOTRIEVE], [CSA]
- Bano Z (1976): The nutritive value of mushrooms. In: First Symposium on Survey and Cultivation of Edible Mushrooms of India. Jammu, RRL, Jammu, Regional Research Laboratory, pp. 148–169.
- Dunn JS, McLetchie NGB (1943): Experimental alloxan diabetes in rats. Lancet 2: 384–387. [CSA]
- Ewart RB, Kornfeld S, Kipnis DM (1975): Effect of lectins on hormone release from isolated rat Islets of Langerhans. Diabetes 24: 705–714. [INFOTRIEVE], [CSA]
- Flegg PB, Maw GA (1976): Mushroom and their possible contribution to world protein needs. Mushroom J 48: 396–405. [CSA]
- Food and Agriculture Organization of the United Nations (1968): Food Composition Table for Use in Africa; A Research Project Sponsored Jointly by U.S. Dept. of Health, Education, and Welfare, Nutrition Program, and Food Consumption and Planning Branch, Food and Agriculture Organization of the United Nations. Bethesda, MD, pp. ix, 306.
- Gray AM, Flatt PR (1998): Insulin-releasing and insulin-like activity of Agaricus campestris. (mushroom). J Endocrinol 157: 259–266. [INFOTRIEVE], [CSA], [CROSSREF]
- Khanna P, Garcha HS (1984): Pleurotus. mushroom—A source of food protein. Mushroom News Letter Tropics 4: 9–14. [CSA]
- Konno S, Tortorelis DG, Fullerton SA, Samadi AA, Hettiarachchi J, Tazaki H (2001): A possible hypoglycaemic effect of maitake mushroom on type 2 diabetic patients. Diabet Med 18: 1010. [INFOTRIEVE], [CSA], [CROSSREF]
- Miles PG, Chang S-T (1997): Mushroom Biology: Concise Basics and Current Development. New York, World Scientific Publishing Company, pp. 1–21.
- Organisation for Economic Co-operation and Development (2001): Guidance Document on Acute Oral Toxicity Testing. Paris, Environment Directorate, OECD, pp. 1–24.
- Rai RD (1986): Souvenir on mushrooms. In: Mushroom: A Perfect Food. Solon, New Delhi, India, pp. 41–42.
- Rao BK, Kesavulu MM, Giri R, Appa Rao C (1999): Antidiabetic and hypolipidemic effects of Momordica cymbalaria. Hook. fruit powder in alloxan-diabetic rats. J Ethnopharmacol 67: 103–109. [INFOTRIEVE], [CSA], [CROSSREF]
- Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey CJ (1989): Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res 10: 69–73. [INFOTRIEVE], [CSA]
- Talpur N, Echard B, Dadgar A, Aggarwal S, Zhuang C, Bagchi D, Preuss HG (2002a): Effects of maitake mushroom fractions on blood pressure of Zucker fatty rats. Res Commun Mol Pathol Pharmacol 112: 68–82. [INFOTRIEVE], [CSA]
- Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi D, Preuss HG (2002b): Antihypertensive and metabolic effects of whole maitake mushroom powder and its fractions in two rat strains. Mol Cell Biochem 237: 129–136. [INFOTRIEVE], [CSA], [CROSSREF]
- Tribe I, Tosco U (1973): The World of Mushrooms. London, Orbis Publishing, pp. viii.
- Wright T (2004): Medicinal mushrooms. In: Rebecca Medley-White, ed., Nutraceuticals World. Ramsey, NJ, Rodman Publishing, pp. 26–29.